A novel, voltage-gated sodium channel cDNA, designated NaCh6, has been isolated from the rat central and peripheral nervous systems.
RNase protection assays showed that NaCh6 is highly expressed in the brain, and NaCh6 mRNA is as abundant or more abundant than the mRNAs for previously identified rat brain sodium channels. Voltage-gated sodium channels (NaChs) supply the regenerative depolarization required for electrical signaling in neurons and muscle cells. These channels are comprised of one (Y subunit WL = 250 kDa) and a variable number of smaller p subunits (see Isom et al., 1994, for review) . Physiologically and pharmacologically different NaChs have been recognized for many years, but the molecular basis for these subtypes has only recently become apparent. These functionally distinct channels could be generated by post-translational modifications since phosphorylation (Lotan et al., 1990; Dascal and Lotan, 1991; Schreibmayer et al., 1991; Gershon et al., 1992; Li et al., 1992; West et al., 1992) , glycosylation (Recio-Pinto et al., 1990) , and association with p subunits (Isom et al., 1992 (Isom et al., , 1994 have been shown to affect NaCh behavior. However, these subtypes can also be a consequence of gene duplication and subsequent divergence since NaChs, like virtually all ion channels in the nervous system, are members of multigene families. Five full-length rat (Y subunit NaCh cDNAs have been published; however, several lines of evidence, both molecular and physiological, indicated that more NaCh cDNAs remained to be isolated and characterized. For example, the combined signal obtained by Northern analysis with probes specific for transcripts of NaChs I, II, and III was less than that obtained using a generic NaCh probe in the retina and PNS (Beckh et al., 1989; Beckh, 1990) . A conservative estimate, based on additional partial cDNAs (Sills et al., 1989; Gautron et al., 1992; D' Archangelo et al., 1993; K. L. Schaller, D. M. Krzemien, and J. H. Caldwell, unpublished observations) , is that there are at least 10 NaCh genes in the rat. The existence of IO NaCh genes creates molecular complexity that is compounded by alternative splicing of the RNA (Sara0 et al., 1991; Yarowsky et al., 1991; Schaller et al., 1992; Gustafson et al., 1993; Thackeray and Ganetsky, 1994) and by post-translational processing. Thus, the discovery of molecular subtypes has surpassed our understanding of the unique roles played by these channels. There are indications that the different NaCh isoforms serve specialized roles. The isoforms are differentially distributed among tissues, in different areas of the CNS and at different times during development (Beckh et al., 1989; Beckh, 1990; Kallen et al., 1990; Trimmer et al., 1990; Brysch et al., 1991; Gautron et al., 1992; Furuyama et al., 1993; Black et al., 1994a) . Single neurons and muscle cells can express more than one NaCh isoform, and some isoforms are localized to different subcellular regions, for example, the soma or the axon (Wollner et al., 1988; Westenbroek et al., 1989) . This segregation of isoforms could permit local regulation of electrical excitability.
An unexpected discovery was that glial cells express NaChs. Toxin binding and patch-clamp recording from Schwann cells and astrocytes unequivocally demonstrated the presence of NaChs (for reviews, see Barres et al., 1990; Ritchie, 1992; Sontheimer, 1994) . The role of voltage-gated NaChs in glial cells is not clear. There is some information about which molecular isoforms are expressed in glial cells. Gautron et al. (1992) reported a partial cDNA that they designated Na-G and considered to be glial because both cultured Schwann cells and cultured astrocytes expressed it. Na-G mRNA abundance was low in the brain, and the Na-G channel was widely expressed in other tissues. A recent study utilizing RT-PCR showed that NaChs I, II, and III are expressed in the optic nerve (Oh et al., 1994) , and since there are no neurons in the optic nerve, they concluded that these isoforms are expressed in glia. Another report showed with in situ hybridization that cultured spinal cord astrocytes express NaCh II, NaCh III, and Na-G but not NaCh I (Black et al., 1994b) .
The full-length sequence of a sixth member (NaCh6) of the family of sodium channels is reported here. We present evidence 3232 Schaller at al. * NaCh6: A Neuronal and Glial Sodium Channel that mRNA for NaCh6 is one of the most abundant sodium channel mRNAs in the brain and that it is widely distributed in both the brain and spinal cord. Finally, NaCh6 is expressed in both neurons and nlia.
Materials and Methods
RNA extraction, RT-PCR, cloning, and DNA sequence analysis. The methods used for the RT-PCR cloning are similar to those previously used (Schaller et al., 1992) . Rat tissues were removed and RNA was isolated with a single-step guanidinium thiocyanate acid-phenol chloroform extraction (Chomczynski and Sacchi, 1987) . Either oligo-dT (I 00 rig/reaction) or random hexamer (500 rig/reaction)-primed synthesis of cDNA was done in 50 ~1 containing 1 kg total RNA, 50 mM Tris (pH 8.3), 75 mM KCI, 3 mM MgCl,, 5 mtvt DTT, 500 FM dNTPs, and 200 U of Moloney murine leukemia virus reverse transcriptase (Bethesda Research Labs). After synthesis at 37°C for 90 min, 250-500 PM of 5' and 3' PCR primers and I U Taq polymerase were added, and the reaction was diluted to 100 pl with sterile H?O. The samples were subjected to two sets of amplification, the first set consisting of five cycles of 2 min at 95"C, 2 min at 48"C, and 2 min at 72°C and the second set consisting of 30 cycles of 2 min at 95°C 2 min at 58°C and 3 min at 72°C. four longest (phagemids 19, 24, 30, and 34) were sequenced on both strands using a series of internal primers as described above.
RNuse protection assay. The RNase protection assay experiments were performed essentially as described previously (Schaller et al., 1992) using the same orobes for RB I, II, III, IIIa, and IIIb. The probe for NaCh6-was constructed by subcloning a portion of the original 845 nt piece (KpnI to SalI, nt 41974610) intopGEM4. cRNA was-prepared by in vitro transcription using either T7 or SP6 polymerase in the presence of IQ~P-CTP (Amersham) as described by Promega, and 5 X 10' dpm of each cRNA was annealed to 50 yg of total RNA in 40 mM PIPES (pH 6.4), 0.4 M NaCI, 1 mM EDT& and 80% formamide for 12-16 hr at 45°C. The labeled orobe was estimated to be at least 100. fold in excess of the NaCh mRNA. The unhybridized RNA probes were digested at 30°C with RNases A and Tl, and the protected probes were analyzed on a 6% polyacrylamide, 8 M urea gel and exposed to x-ray film. The relative abundance of the various isoforms was analyzed by direct measurement of radioactive decay (PhosphoImager, Molecular Dynamics). Controls for nonspecific hybridization consisted of (I) the sense strand for each probe and (2) the antisense probe hybridized to liver RNA or to tRNA. No signal was present in any of the controls. An aliquot (500 dpm) of the labeled probe was loaded onto the gel to indicate the size of the unprotected probe.
The initial RT-PCR cloning was performed using a 5' primer which extended from nucleotide (nt) 3835 to 3866 (nucleotide numbers refer to rat NaCh I described by Noda et al., 1986) with an additional 14 nt at the 5' end comprising Sph I and Hind III restriction endonuclease sites; the 3' primer extended from nucleotide 4660 to 4681 with an additional 14 nt comprising Sal1 and EcoRI restriction sites, giving an expected DNA amplification product of 845 base pairs (bp). An additional region (more 3' and overlapping with the 845 bp piece) was obtained by RT-PCR using generic primers from nt 4434 to 4460 and nt 5617 to 5643.
The RT-PCR cloning of the approximately 1.5 kb of the missing 5' end was done using four sets of overlapping primers. One set of generic, degenerate primers was used to amplify a cDNA of 602 bp (primers extended from nt 244 to 269 and nt 824 to 845, each with 48-fold degeneracy), and another set of generic, degenerate primers was used to amplify a cDNA of 710 bp (primers extended from nt 580 to 603 and nt 1268 to 1289, with fourfold and 256-fold degeneracy, respectively). After these amplifications, products were cloned and sequenced as described below. NaCh6-specific primers were designed to amplify cDNAs to bridge the gaps; a 191 bp cDNA was amplified using primers extending from nt 1180 to 1200 and 1345 to 1370. For amplification of the very 5' end (387 nt), a threefold degenerate oligonucleotide extending from -13 nt to +3 nt was used with a specific oligonucleotide for NaCh6 extending from nt 353 to 373. Each of the cDNA regions cloned by RT-PCR had an overlap of loo-250 nt with the adjacent pieces, and, when sequenced, these overlaps were identical except in the regions where the primers were known to be degenerate.
After amplification, the DNA was gel purified from a 1% agarose gel using GeneClean (Bio 101) digested with the appropriate restriction endonuclease, and ligated to either MP19 or pBluescript, also restricted with the appropriate restriction enzymes. Recombinant DNA templates were prepared by standard methods (Sambrook et al., 1989) . These DNAs were sequenced with a series of internal oligonucleotide primers by the dideoxy method using Sequenase (USB) according to the manufacturer's instructions. The sequence analysis and homology comparisons were done using PCGENE (Intelligenetics).
Some of the clones had a deletion which would remove half of IIIS3 and all of IIIS4. Every clone from the transformed PC12 cell line had this deletion, and some of these clones had a short insertion (63 nt) at the deletion site. These transcripts could reflect improper splicing or a means of regulating expression-of the transcript.
Lihrurv screen. An oliao-dT-mimed adult rat brain librarv, kindly provided'by Dr. T Snutchv (UniGersity of British Columbia), plated at 50,000 pfu per 150 mm plate (750,000 total), was transferred to nitrocellulose filters in duplicate. An oligonucleotide probe specific for NaCh6 (oligo 6A2, see below) was 5'-end-labeled with '*P-y-ATP using T4 Kin&e <Bethesda Research Labs), and hybridized to the filters for 16 hr at 40°C in 6X SSC. 20 IIIM NaH,PO,. 0.4% SDS, 100 up/ml yeast tRNA, and 100 p,g/ml denatured salmon sperm DNA. The'filters were washed at 40°C in 6X SSC, 0.1% SDS, and exposed to x-ray film. After three rounds of plaque purification, the 35 positive phage obtained were transformed into Bluescript phagemids by in viva excision. The Northern unulysix RNA gel electrophoresis, gel blotting, and hybridization were performed essentially according to Sambrook et al. (I 989) . Total RNA (50 kg/lane) was electrophoresed through a 0.8% agarose gel containing 6% formaldehyde. The RNA was transferred to Zetaprobe membrane (Bio-Rad). Hybridizations were performed 16 hr at 65°C in 6X SSC, 5X Denhardt's, 1% SDS, 200 yg/ml denatured salmon sperm DNA, 100 p+g/ml yeast tRNA, and 1 X 10" dpm/ml of ??P-labeled antisense riboprobe containing the 3' UTR from-phagemid 30. The membranes were washed in 0.2X SSC. 1% SDS at 70°C. and exuosed to x-ray film for 16-48 hr. An RNA ladder (Bethesda Research Labs) consisting of poly A transcripts ranging in size from 0.24 to 9.5 kb was used to size the NaCh6 transcript.
In situ hybridization and anti-GFAP immunocytochemistry. One sense and two antisense oligonucleotide probes were constructed against NaCh6 cDNA sequences: ?-CTGCTGCAATGGCCACCTCAGCGGG-3' (olieo 6Sl). nt 1345-1370: S'-TATCGATTTCGAACCGGATTT- \-us CAGAAGTCTCA-3' (oligo 6Al), nt 4062409 1; and 5'.CCCGCTGA-GGTGGCCATTGCAGCAG-3' (oligo 6A2), nt 1345-l 370. These sequences were specific for NaCh6 and were selected to show little sequence homology to other NaCh genes or any other sequence in the EMBL or GeneBank databases. The nucleotide identity between oligo 6Al and the other isoforms ranged from 30% to 53% (NaCh I, 40%; NaCh II, 33%; NaCh III, 53%; SkMl, 37%; SkM2, 30%). The nucleotide sequence of 6A2 and 6Sl was not present in muscle isoforms and was 44448% identical to brain isoforms (NaCh I, 48%; NaCh II and III, 44%). In situ hybridization and immunocytochemistry experiments were performed using a modification of the procedure of Mahalik et al. (1992) . Rats were transfused through the heart with 4% paraformaldehyde in PBS (0.1 M phosphate buffer, pH 7.6; 0.9% NaCl) and the brains and spinal cords removed, stepped through 20% sucrose in PBS for 24 hr followed by 30% sucrose in PBS for 24 hr, and frozen at ~80°C until they were sectioned. Sections were taken both coronally and parasagittally (25 ym) through the brain, and transversely through the spinal cord. The sections were rinsed in 1 X SSC and then placed in hybridization buffer (50% formamide, 10% dextran sulfate, 4X SSC, 0.5X Denhardt's, 5 mM DTT, 250 kg/ml denatured salmon sperm DNA, and 250 kg/ml yeast tRNA) containing 1.0 X 10" dpm of 'S-labeled oligonucleotide probe per 100 ~1. The oligonucleotide probes were labeled at the 3' ends using terminal transferase (Stratagene) in the presence of Yj-dATP (New England Nuclear); specific activities ranged from 1 X lox to 5 X 108. After hybridization at 26°C for 1624 hr, the sections were washed in 1 X SSC at 26°C for 30 min followed by a 30 min wash in 0.2X SSC at 45°C and then were either mounted onto gelatin-coated slides and allowed to air dry or processed for immunocytochemistry as follows.
The sections were briefly washed in PBS and blocked with 10% BSA (bovine serum albumin), 0.3% Triton X-100 in PBS for 1 hr at room temperature. The sections then were incubated in 2% BSA, 0.3% Triton X-100 in PBS containing a mouse monoclonal antibody (Boehringer Mannheim) against GFAP (glial fibrillary acidic protein) at 4°C for 16-24 hr. The sections were washed in PBS and placed in 2% BSA, 0.3% Triton X-100 containing a biotinylated rat polyclonal sera (Jackson Laboratories) against mouse IgG for 2 hr at room temperature. The sections were again washed, then reacted with an avidin-biotin complex, and the immunoreactivity visualized with diaminobenzidine. The sections were mounted onto gelatin-coated slides and exposed to B-Max hyperfilm (Amersham) for 40-48 hr at room temperature. Following this, the slides were dipped in Kodak NTB-2 emulsion and exposed for l-3 weeks at 4°C. The emulsion-dipped slides were developed in Kodak D-19 developer, fixed, counterstained with cresyl violet, dehydrated, and coverslipped. The slides were photographed using a Zeiss Axiophot microscope.
Controls used to assure specificity of the i n situ hybridization experiments were a sense probe that gave no specific hybridization, and hybridization with 'X-labeled antisense oligonucleotides that could be blocked by incubation with an excess (25-50-fold) of the same unlabeled oligonucleotide (see Fig. 5 ).
Astrocyte cultures.
Primary astrocyte cultures were prepared and maintained as described by Yarowsky and Krueger (1989) . Cerebral hemispheres of newborn rats were removed, placed in modified DMEMI F12 medium with 10% fetal calf serum, cleaned of meninges, trimmed, and mechanically disrupted by vortexing. The cell suspension was then filtered, first through 80 FM sterile nylon sieving cloth, then through 10 pm cloth, and plated at a density of 2-3 X IO" cells per 35 mm dish. An immortalized astrocyte cell line (A7) was maintained in medium RPM1 1640 containing 10% fetal bovine serum. For i n situ hybridization/immunocytochemistry, both primary and immortalized astrocyte cells were grown on poly-L-lysine-coated coverslips in the appropriate medium, fixed for 10 min in 4% paraformaldehyde, washed in PBS, dehydrated, and frozen at -80°C until used.
Results
Cloning c$ NaCh6 cy subunit cDNA Since there was evidence for additional NaChs in the CNS, PNS, and in glial cells, we isolated partial NaCh cDNA clones using RT-PCR with RNA isolated from a variety of rat tissues including brain, retina, and dorsal root ganglia, as well as from retrovirally transformed PC12 cells and primary cultures of neonatal rat cortical astrocytes. We chose to use PCR primers that amplified an 845 nucleotide region from IIIS3 to IVSI ( Fig. 1 ) because we have successfully amplified NaCh cDNAs from a wide range of species with these primers. Partial cDNAs for NaCh6 were obtained from all of the sources described above. From the sequence of the PCR product, an oligonucleotide specific for NaCh6 was synthesized and used to screen a rat brain oligo-dT-primed cDNA library (a gift of Dr. Terry Snutch). All of the 35 clones that were isolated contained the 845 nucleotide sequence obtained by PCR. We analyzed the four longest clones (Fig. I) . The most 5' clone (phagemid 34) was approximately 4700 nucleotides in length; it began near the 3' end of IS6 and included 71 nucleotides of 3' untranslated sequence (Fig. 1 ). Further screening of this library and the other 34 positive clones with an oligonucleotide near the 5' end of p34 did not yield any clones with additional 5' sequence. Screening of additional libraries was also unsuccessful.
Therefore, RT-PCR was used to amplify and clone the missing 5' end of the cDNA. RNAs from neonatal rat astrocyte cultures and from adult rat brain were used with four sets of overlapping primers, some of which were generic for all NaChs and others which were specific for NaCh6 (see Materials and Methods). Multiple individual clones were sequenced for each of the primer pairs to ensure that Taq polymerase errors were excluded. Identical nucleotide sequences were obtained where adjacent PCR products overlapped (loo-250 nt of overlap). This strategy yielded the full-length sequence of the coding region (1976 amino acids) with a predicted molecular weight for the protein of 225,227 daltons (Fig. 2) . This cDNA has been designated rat NaCh6 because it is the sixth full-length rat NaCh sequence to be published. In addition, a neutral name is appropriate for a channel that we show below to be expressed throughout the nervous system and in both neurons and glia.
The primary amino acid sequence has the same predicted secondary structure as five published rat NaChs. There are four large membrane-spanning domains (I-IV), each with six predicted transmembrane (Y helices (Sl-S6) and two highly conserved regions (SSl and SS2) that are thought to form part of the pore. Predicted transmembrane domains and a short cytoplasmic domain critical for inactivation (interdomain III-IV) are highly conserved among the known rat NaCh cDNAs (Fig. 2) . These regions have 74-94% amino acid identity with NaCh6 
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( Table 1 ). The large cytoplasmic domains are more divergent, with about 30-70% identity between NaCh6 and the brain or muscle channels, and a comparison of these cytoplasmic regions shows that NaCh6 is more similar to brain than to muscle NaChs.
Northern analysis
Northern analysis was performed on RNA isolated from different tissues (Fig. 3) . A riboprobe for the 3' untranslated region was used to detect NaCh6 mRNA. Two bands, a prominent one at 9.5 kb and a fainter one at 10.4 kb, were detected in brain, cerebellum, and spinal cord. No transcripts were detected in kidney, lung, uterus, and skeletal and cardiac muscle. The reason for the two different transcript sizes is not known. One possibility is that the length of the 3' untransjated region is variable, due either to the use of different polyadenylation signal sites, as suggested for NaCh III (Suzuki et al., 1988) , or to alternative splicing.
mRNA abundance We used RNase protection analysis, which is both specific and sensitive, to quantitate the abundance of NaCh6 mRNA. The abundance of NaCh6 mRNA was compared to that of NaChs I, II, and III and to alternative splicing isoforms of NaChs I and III (Schaller et al., 1992) . Figure 4 shows the results of RNase protection with each of these probes to adult rat brain RNA. The relative abundances of the labeled bands in Figure 4 were quantitated by measuring the radioactive decay with a PhosphoImager. The ratios of NaCh6:NaCh 1:NaCh 1a:NaCh II/IIa:NaCh 1II:NaCh 1IIa:NaCh IIIb were 1:0.14:0.83:0.75:0.17:0.07:0.02. Thus, the RNA protected by NaCh6 was as abundant as the RNA of any of the isoforms of NaChs I, II, or III. Given this abundance, it is surprising that this channel was not cloned earlier.
Glial expression of NaCh6 None of the experiments described above indicated what cell types in the nervous system express NaCh6. The ability to amplify and clone NaCh6 cDNA from RNA of primary cultures of cortical astrocytes suggested that this channel is expressed in astrocytes. However, PCR is extremely sensitive, and since these cultures are not purely of one cell type (Yarowsky and Krueger, 1989) , we performed in situ hybridization in combination with GFAP immunocytochemistry to confirm that NaCh6 mRNA was expressed in cultured astrocytes. The specificity of the in situ hybridization results was assured by the use of synthetic oligon- ucleotides, rather than a larger cDNA clone, as hybridization probes, since over the length of the coding region NaCh6 shows 6570% identity with the previously cloned rat brain cDNAs. Two antisense oligonucleotide probes specific for NaCh6 were synthesized, one for a cytoplasmic region (oligo 6A2) and the other for an extracellular region (oligo 6Al). As a control, one sense oligonucleotide probe was synthesized. The oligonucleo- Figure 4 . RNase protection to quantitate NaCh isoforms. Riboprobes were made that were specific for NaChs I, II, III, 6 and several splicing isoforms (Ia, IIIa, and IIIb) that we characterized previously (Schaller et al., 1992) . These probes, in loo-fold excess, were hybridized to RNA from brain, and the protected RNAs were electrophoresed on a polyacrylamide gel and analyzed by a PhosphoImager that quantitates the radioactivity in the gel. The right halfof the image shows the protected mRNA fragments. The left half shows an aliquot of the unprotected probes. The$first Zune on rhe right has three heavily labeled bands (arrows); the top band (435 nt) is NaCh I mRNA and the two lower bands are protected fragments of NaCh Ia mRNA, which has an 11 amino acid deletion relative to Ia and causes the NaCh I probe to be cut into two pieces (156 and 246 nt). The signal from isoform IIIa is nine nucleotides longer than III. The signal from isoform IIIb (96 nucleotides longer than III) was too weak to be visible at this exposure. tide probes for NaCh6 were designed by choosing regions where the number of mismatches between the oligonucleotide and the other isoforms was maximized (see Materials and Methods). Three results were consistent with the probes being specific for NaCh6. First, in situ hybridization with these two different antisense probes showed strong labeling ( Fig. 5A ) and identical patterns of expression of NaCh6. In situ hybridization showed little labeling with the sense probe (Fig. 5B ) or when excess unlabeled antisense probe was added to compete with the labeled antisense probe (Fig. 5C ). Second, oligonucleotide 6Al was used to screen a rat brain library (described above), and all of the 35 clones isolated were NaCh6. Third, oligonucleotide 6A2 was used with a degenerate generic NaCh primer for RT-PCR amplification. Sequencing of individual partial cDNA clones (five clones) from the RT-PCR showed that all these cDNAs were NaCh6. Primary cultures (2-3 weeks old) of neonatal rat astrocytes were fixed and hybridized with NaCh6 sense or antisense oligonucleotide probes that were end labeled with ?S-dATP Each of the antisense probes gave the same result: virtually all cells were labeled (Fig. 6A,B) . There was no specific labeling with the sense probe. Immunocytochemical labeling with anti-GFAP antibody showed that over 95% of the cells in these cultures were GFAP positive (Fig. 6C) . Thus, the in situ hybridization demonstrated that cortical astrocytes (GFAP positive) in culture express NaCh6 mRNA.
In addition to the PCR amplification from cultures of astrocytes, two experiments further indicated that astrocytes express NaCh6. When the CNS is injured, astrocytes respond by proliferating and forming scar tissue. The scar is created by the generation of astrocyte processes that are especially abundant in glial intermediate filaments composed of GFAP Cryostat sections of a rat brain that had been lesioned (by insertion of a needle into the cortex and striatum) 10 d prior to death were incubated with the NaCh6 probe. The cells most heavily labeled were cells on the border of the lesion (Fig. 60) , and these cells had processes that were intensely labeled by the antibody against GFAP The second line of evidence came from an immortal cell line (A7) generated from the rat CNS that has many properties of astrocytes (Geller and Dubois-Dalcq, 1988) . These cells were labeled by an NaCh6 antisense probe but not by the sense probe (Fig. 6E, F) .
It was possible that astrocytes in culture expressed NaCh6 as a consequence of the isolation and culture conditions. To test for in vivo expression in glia in normal, adult rats, we performed in situ hybridization on sections of the brain and spinal cord (Fig. 7) . Due to the intimate intermingling of neurons and glia in most regions of the CNS, it was difficult at the light microscopic level to determine unequivocally if glial cells were labeled. Therefore, white matter tracts were examined for labeled cells.
Spinal cord sections allowed clear identification of labeled glia in the white matter. Cells that were associated with GFAPpositive processes in the white matter were labeled ( Fig. 7A,B ; small arrows illustrate a few of these). It is unlikely that these labeled cells were oligodendrocytes because oligodendrocytes are GFAP negative, are more abundant than the labeled cells we observe, and have never been found to express Na currents in electrophysiological recordings. These cells are also not likely to be neurons because the occurrence of neurons in spinal cord white matter is rare (Donald, 1953) . Thus, we conclude that astrocytes in white matter of the spinal cord express NaCh6.
In situ hybridization indicated that Schwann cells express NaCh6. Heavy, relatively uniform labeling of dorsal roots was observed (Fig. 7A) . Dorsal root labeling stopped abruptly at the zone of Obersteiner-Redlich (large arrow in Fig. 7A ), the location at which glial cells change from peripheral (Schwann cells) to central (oligodendrocytes). The GFAP labeling also changed at this transition zone; it became weak or nonexistent distal to the zone. Since axons do not contain mRNA, labeling with the NaCh6 probe is consistent with reports that Schwann cells express NaChs while oligodendrocytes do not.
Examination of white matter tracts in the brain was less clear cut than in the spinal cord. Some labeling was evident in cerebellar white matter (Fig. 7E) . However, there was little labeling of the optic nerve (Fig. 7C ) compared to the adjacent region of the hypothalamus above the chiasm. There was also some labeling of two commissural tracts: the corpus callosum and the hippocampal commissure (Fig. 5A ). Thus, it is possible that expression of NaCh6 is heterogeneous in astrocytes (see Discussion).
Neuronal expression of NaCh6
The distribution of NaCh6 was widespread in the spinal cord and brain. Examples of neuronal labeling in the CNS are presented (Fig. 7) . Many cells in the gray matter of the spinal cord were labeled, but the type of cell often could not be determined. However, some of the largest neurons were clearly labeled. Motor neurons, identified by their size and position, showed intense labeling (Fig. 7B) , as did preganglionic sympathetic neurons in the intermediolateral cell column (not shown). Primary motor 3238 Schaller at al. l NaCh6: A Neuronal and Glial Sodium Channel E, Cerebellum. Antt\ense oligonucleottde hybridized strongly to the granule cell layer, moderately and uniformly to the molecular layer, and weakly to the white matter tracts entermg and leavmg the cerebellar cortex. Some cells m the molecular layer were labeled. GFAP labehng of Bergmann gha was evident in the molecular layer. F, Cerebellum. Hybridization of a sense probe was at or near background m the granule cell (g) and molecular (m) layers. Scale bar: 200 pm for A, B, E, and F, 500 pm for C, and 50 pm for D neurons in the brainstem, for example, in the facial nucleus (Fig.  70) were labeled.
In the cerebellum Purkinje cells were labeled, and the cerebellar granule cell layer was heavily labeled (Fig. 7E) . Much of this labeling was in granule cells since identification of astrocytes by anti-GFAP antibodies in sections hybridized with the sense probe (Fig. 7F) showed that GFAP-positive astrocytes were not abundant enough to account for all of the labeling in the granule cell layer. A few isolated cells in the molecular layer were labeled. Neurons in the deep cerebellar nuclei were also labeled (not shown). We conclude that NaCh6 mRNA is present in many types of neurons in the cerebellum.
In the hippocampus, granule cells of the dentate gyrus and pyramidal cells were labeled (not shown). There did not appear to be any obvious difference in labeling of CA1 versus CA3 pyramidal cells, or in granule cell labeling within the dentate gyrus.
There was no obvious rostral-caudal gradient of NaCh6 mRNA from in situ hybridization. This is in contrast to what has been found for the distribution of NaChs I and II; NaCh I is most abundant in the caudal CNS and the opposite is true for NaCh II (Beckh et al., 1989) . NaCh III, unlike NaCh6, is expressed at low levels in the adult brain, with little or no expression in the cerebellum (Furuyama et al., 1993; Black et al., 1994) . Thus, NaCh6 not only is broadly expressed throughout the CNS but also has a distribution different from that of the other brain NaChs.
Discussion
The two most significant aspects revealed by isolation of NaCh6 are, first, that it is one of the most abundant NaChs in the nervous system at the RNA level and, second, that it is expressed in both neurons and glia. Beckh et al. (1989 Beckh et al. ( , 1990 showed with Northern blot analysis that NaChs I, II, and III did not account for all the NaCh mRNA in the rat nervous system. The signal they obtained using a generic cDNA probe was larger than the combined signal for probes specific for NaChs I, II, and III, suggesting the existence of one or more novel NaCh mRNAs. Using RT-PCR, NaCh6 was shown to be in many of these tissues, including retina and dorsal root ganglia. RNase protection analysis (Fig. 4) showed that the amount of NaCh6 mRNA was at least as abundant as that of rat brain NaChs I, II, and III, including the isoforms generated by alternative splicing. In situ hybridization with a probe specific for NaCh6 (Fig. 7) was consistent with the RNase protection; many areas of the brain and spinal cord were heavily labeled. DRG neurons were also labeled (Schaller, Krzemien, and Caldwell, unpublished observations). Areas of the CNS expressing NaCh6 can be compared to areas labeled with in situ hybridization using probes specific for NaChs I, II, and III (Brysch et al., 1991; Furuyama et al., 1993; Black et al., 1994a) . There was overlap in distribution, but none of the other channels had the same distribution as NaCh6. Thus, we conclude that NaCh6 is an abundant NaCh in the adult rat CNS and has a broad distribution that is different from the distributions of the other brain NaChs.
Schwann cells and astrocytes express voltage-gated sodium channels (Barres et al., 1990; Ritchie, 1992; Sontheimer, 1994) . The specific NaCh isoforms expressed in glia are beginning to be characterized. NaChs I, II, and III have been shown to be expressed in glia (Black et al., 1994; Oh et al., 1994b) . In addition, a partial NaCh cDNA (designated Na-G) expressed in glia has been reported (Gautron et al., 1992) . The Na-G transcript is very different from NaCh6 in both sequence and distribution.
From amino acid sequence comparisons, all of the full-length NaChs in Figure 2 , including NaCh6, belong to one family. A second NaCh family is formed by Na-G and hNa,2. I (a human cDNA obtained from cardiac muscle; George et al., 1992) ; amino acid similarities between cDNAs of these two families are much lower (about 50-60% for transmembrane regions and 5-45% for the large cytoplasmic regions) than those within a family (Table 1 ). The tissue distribution of Na-G is also very different from that of NaCh6. Na-G is expressed in uterus, lung, and cardiac muscle, while NaCh6 was not detected in these tissues (Fig. 3) . In the brain and adult spinal cord there is a low abundance of Na-G (Gautron et al., 1992) , in contrast to the high abundance of NaCh6 (Fig. 4) . Thus, although both NaCh6 and Na-G are expressed in glial cells, the comparisons of tissue abundance and distribution suggest that they play different roles in glia of the CNS.
The strong amino acid identity in the transmembrane regions (Table 1 , Fig. 2 ) leaves no doubt that this novel cDNA encodes a sodium channel. All four S4 transmembrane segments that are thought to function as the voltage sensor are completely conserved (i.e., amino acids of NaCh6 are identical to those of either brain or muscle), and the short cytoplasmic domain between transmembrane domains III and IV, which is crucial for inactivation, is almost totally conserved (52 of 53 amino acids identical to either brain or muscle sequences). Two amino acids (K1409 and A1701) that distinguish between Na and Ca permeability (Heinemann et al., 1992) are also consistent with the identification of NaCh6 as a sodium channel. The major differences between NaCh sequences lie in the intra-and extracellular domains (Table 1 ). The size of these domains in NaCh6 is closer to brain than muscle NaChs. These domains contain potential sites for post-translational modifications, for example, by phosphorylation or glycosylation (Fig. 2) . Functional expression will be necessary to determine the effects of phosphorylation or glycosylation, as well as the voltage dependence, kinetic properties, and toxin sensitivity that are unique to NaCh6.
NaChs are essential for electrical excitability in the nervous system. The classic example of this is the conduction of action potentials in myelinated and nonmyelinated axons. However, there is increasing evidence that NaChs are employed for more subtle, subthreshold, signal processing in neurons. NaChs are found in the dendrites of cerebellar Purkinje cells (Regehr et al., 1992) and of pyramidal cells in both the hippocampus (Regehr et al., 1993) and cortex (Huguenard et al., 1989; Stuart and Sakmann, 1994) . These NaChs are capable of generating dendritic action potentials, and their density and distribution in dendrites will modify synaptic responses. In order to understand the effect of NaChs on synaptic integration, it is essential to know for each class of neuron what NaCh isoforms are present and the properties and distribution of each isoform. All the NaChs isolated from nervous tissue, including NaCh6, have been shown to be expressed in glia. Since astrocytes are biochemically and morphologically heterogeneous, it will be important to determine the isoforms expressed in each astrocyte subtype. In addition, there is evidence that NaChs are segregated to different regions of the astrocyte, for example, in the processes (Barres et al., 1990) and in apposition to nodes of Ranvier (Black et al., 1989) . Thus, the distribution of NaChs in glia may be as complex as that in neurons. Knowledge of
The Journal of Neuroscience, May 1995, 15(5) 3241 the biophysical properties and subcellular localization of each NaCh isoform will be essential for determining why glia express voltage-gared NaChs. Antibodies that are specific for NaCh6 will be valuable tools for determining the subcellular distribution in both neurons and glia. GenBank accession number. The accession number for the NaCh6 sequence is L390 18.
